GlassScriptPhysician profile
Aliya Mushtaq
NPI 1912158387
$7,969.94
in general payments reported to CMS, 2019-2025
47 companies · $1,148 in 2025
The $1,148 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $503 · 2021: $1,464 · 2022: $2,212 · 2023: $1,088 · 2024: $1,080 · 2025: $1,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,221 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,220.92 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,234.45 | 2019-2024 | Impella |
| Amgen INC. | $666.16 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $643.59 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $446.77 | 2019-2025 | |
| Boston Scientific Corporation | $321.95 | 2023-2025 | Avvigo Guidance System, Bodyguardian, Watchman |
| Baxter Healthcare | $309.29 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $306.72 | 2020-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $279.10 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $269.19 | 2021-2025 | Verquvo |
| Irhythm Technologies, INC. | $266.97 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.26 | 2021-2025 | Jardiance |
| Amarin Pharma, INC. | $214.34 | 2019-2021 | |
| Abbott Laboratories | $212.27 | 2019-2025 | Cardiomems |
| Pfizer INC. | $208.26 | 2019-2025 | |
| Biosense Webster, INC. | $200.83 | 2023-2024 | Carto 3 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aliya Mushtaq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.